{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-052216","form_type":"8-K","ticker":"IMA","cik":"0001835579","company_name":"ImageneBio, Inc.","filed_at":"2022-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.700872+00:00","generated_at":"2026-06-27T05:02:34.906014+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Ikena Oncology appoints Francisco Olivera as acting Principal Accounting Officer (Feb 18, 2022)","bullets":["Appointment made effective February 18, 2022, on an interim basis while a formal CFO search is conducted.","Olivera currently serves as VP of Finance, joined the company in 2019, and has over a decade of biotech experience.","He played a key role in the IPO, Series B financing, and acquisition of Amplify Medicines.","No arrangements or understandings exist with any other person regarding the appointment; no related party transactions reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-052216","json":"https://secwatch.observer/filing/0001193125-22-052216.json","markdown":"https://secwatch.observer/filing/0001193125-22-052216.md","text":"https://secwatch.observer/filing/0001193125-22-052216.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835579/000119312522052216/0001193125-22-052216-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835579/000119312522052216/d305562d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T05:02:34.906014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3a78369309","claim":"Francisco Olivera was appointed as acting Principal Accounting Officer at ImageneBio, Inc..","evidence_excerpt":"On February 18, 2022, the Board of Directors (the “Board”) of Ikena Oncology, Inc. (the “Company”) unanimously appointed Francisco Olivera as the acting Principal Accounting Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835579/000119312522052216/0001193125-22-052216-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"acting Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"9c343b0a49","claim":"Douglas R. Carlson resigned as other_named_officer at ImageneBio, Inc..","evidence_excerpt":"This appointment has been made in connection with the effectiveness of the resignation of Douglas R. Carlson, as previously disclosed on January 28, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835579/000119312522052216/0001193125-22-052216-index.htm","confidence":0.85,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}